Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
See tonight’s solar storm unfold across the world - 2They want better health care — so they're turning to crypto startups
- 3The most effective method to Move toward Compensation Conversations for Cutting edge Practice Enrolled Attendants
- 4'Wuthering Heights' trailer features Margot Robbie and Jacob Elordi in a steamy forbidden romance
- 5Explora Journeys becomes latest cruise line to be impacted by Middle East war
- ADHD drugs work, but not the way experts thought
- The Quadrantid meteor shower peaks tonight, but will the full 'Wolf Moon' outshine the show?
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
- 15 Preposterous Cosplay Ensembles That Will Blow You Away
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
- PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
- Farmers call for French blockades over cow disease cull
- The Magnificence of Do-It-Yourself Skincare: Regular Recipes and Tips
